KTTA Pasithea Total Business Assets
The development of Pasithea Therapeutics (KTTA) relies on successes in creating drugs for CNS pathologies and substantial capital, although expansion is hindered by intense pressure from resource-rich pharma behemoths. This price chart illustrates total assets at 34.36. Meanwhile, the brand maintains moderate appeal among physicians and cautious optimism among specialized investors.
Analytical breakdowns and data insights for company pasitheaclinics.com (KTTA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Pasithea Therapeutics|KTTA - Long-Term Debt to Equity|Current Liabilities to Capital Pasithea Therapeutics Corp.|KTTA - Company Debts|Debts to Book Capitalization Ratio Pasithea Therapeutics Corp.|KTTA - Company Long-Term Debts|Company Short-Term Debts Pasithea Therapeutics|Interim Coverage Ratio pasitheaclinics.com
- company profitability and valuation multiples indicators:
Basic company analysis:Pasithea KTTA
Total assets represent the aggregate value of all corporate resources, calculated inversely via ROA to eliminate market noise, allowing GURU.Markets investors to track capital dynamics across Pasithea Therapeutics (KTTA) assets based on ROA and assess the risk of capital erosion, particularly now that the stabilized management of Pasithea Therapeutics must maintain strict financial discipline while implementing clinical programs.
Direct competitors
biogen.com (BIIB) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|amylyx.com - Total Asset Value of Company|Company Total Assets TRVI|Company Total Assets Praxis Precision Medicines Inc (PRAX)|Aggregate Company Assets Anavex Corp AVXL|Company Total Asset Base CeriBell EEG (CBLL)|Prothena Corporation plc - Company Total Assets|Company Total Asset Base Alector, Inc. ALEC|ANNX (Annexon) - Cumulative Company Assets|OMER: Aggregate Business Assets|NGNE (Neurogene Corp) - Company Total Assets|ACIU: Aggregate Asset Value|Company Total Assets VYGR|NMRA - Company Assets|Company Total Assets SCLX (Scilex)|Company Total Assets Tevogen Bio Holdings Inc. TVGN|ACOG: Cumulative Company Assets|Aggregate Asset Value CGTX (Cognition Therapeutics Inc.)|IKT (Inhibikase Therapeutics) - Cumulative Company Assets|SAVA: Aggregate Business Assets|ASRT (Assertio Holdings) - Company Total Assets|COYA: Aggregate Asset Value|Company Total Assets VTGN|OVID - Company Assets|Aggregate Company Assets Acumen Pharmaceuticals ABOS|Aggregate Asset Value CRVO|Alterity Therapeutics Ltd - Company Total Assets|CLNN - Company Total Assets|pepgen.com (PEPG) - Aggregate Company Assets|Total Asset Value of Company JUNS (Jupiter Neurosciences, Inc.)|RLMD (Relmada Therapeutics) - Company Total Assets|Company Assets annovisbio.com ANVS|Cumulative Company Assets GRCE (Grace Therapeutics, Inc.)|Company Total Assets Firefly Neuroscience, Inc. (AIFF)|Klotho Neurosciences - Cumulative Company Assets|Aggregate Business Assets NRSN (NeuroSense Therapeutics Ltd)|Reviva Pharmaceuticals - Company Total Assets|Company Total Asset Base MetaVia Inc MTVA|NRXS: Company Total Assets|Cumulative Company Assets Helius Medical Technologies|Aggregate Company Assets Passage Bio Inc.|Neuphoria (NEUP) - Company Total Asset Base|Aggregate Company Assets Minerva Neurosciences (NERV)|Company Total Assets athira.com (ATHA)|Addex Therapeutics Ltd - Cumulative Company Assets|Aggregate Business Assets ALZN (Alzamend Neuro Inc.)|CYCN: Cumulative Company Assets|Protagenic Therapeutics - Aggregate Business Assets|CRGT: Company Total Assets|avenuetx.com (ATXI) - Company Total Assets|Aggregate Company Assets BrainStorm Cell Therapeutics|Total Business Assets CARA (Cara Therapeutics Inc.)|Company Total Assets CHRO|ELYM - Company Assets|Intra-Cellular Therapies, Inc. - Cumulative Company Assets|Company Total Assets longboardpharma.com LBPH|MRNS - Aggregate Company Assets|Aggregate Asset Value NKGN (NKGen Biotech Inc)|NeuroBo (NRBO) - Aggregate Company Assets|Company Assets Sage Therapeutics Inc (SAGE)|Aggregate Company Assets Synaptogenix, Inc.|trevena.com - Total Asset Value of Company|Company Total Assets VIGL|Company Total Assets anewmeds.com (WENA)|Aggregate Company Assets Cerevel CERE